Cannabidiol diacetate
Cannabidiol Diacetate
Cannabidiol Diacetate (CBDDA) is a synthetic derivative of cannabidiol (CBD), a major non-psychoactive component of the Cannabis sativa plant. CBDDA is formed by the acetylation of CBD, resulting in the addition of two acetate groups to the molecule. This modification can alter the pharmacokinetic properties of the compound, potentially affecting its absorption, distribution, metabolism, and excretion.
Chemical Structure and Properties
Cannabidiol Diacetate is characterized by the presence of two acetate groups attached to the CBD molecule. The chemical structure of CBDDA can be represented as C23H32O4. The addition of acetate groups increases the lipophilicity of the compound, which may enhance its ability to cross biological membranes.
Synthesis
The synthesis of Cannabidiol Diacetate involves the acetylation of cannabidiol. This process typically uses acetic anhydride in the presence of a catalyst to introduce the acetate groups. The reaction is carried out under controlled conditions to ensure the selective acetylation of the hydroxyl groups present in CBD.
Pharmacology
The pharmacological effects of Cannabidiol Diacetate are not as extensively studied as those of cannabidiol. However, it is hypothesized that the acetylation of CBD may influence its interaction with the endocannabinoid system, potentially altering its affinity for cannabinoid receptors such as CB1 and CB2.
Potential Applications
Research into the potential applications of Cannabidiol Diacetate is ongoing. Like CBD, it may possess anti-inflammatory, analgesic, and neuroprotective properties. However, further studies are needed to fully understand its therapeutic potential and safety profile.
Legal Status
The legal status of Cannabidiol Diacetate varies by jurisdiction. As a synthetic derivative of CBD, it may be subject to different regulations compared to naturally occurring cannabinoids. It is important to consult local laws and regulations regarding the use and distribution of CBDDA.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD